Literature DB >> 22212974

52-year-old man with liver enzyme abnormalities and elevated ferritin level.

Eric M Nelsen1, Darrell B Newman, Seth Sweetser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22212974      PMCID： PMC3498216          DOI： 10.1016/j.mayocp.2011.08.004

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  10 in total

Review 1.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

2.  Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.

Authors:  Shivakumar Chitturi; Geoffrey C Farrell; Etsuko Hashimoto; Toshiji Saibara; George K K Lau; José D Sollano
Journal:  J Gastroenterol Hepatol       Date:  2007-06       Impact factor: 4.029

Review 3.  Diagnosis and management of hereditary haemochromatosis.

Authors:  M A van Bokhoven; C Th B M van Deursen; D W Swinkels
Journal:  BMJ       Date:  2011-01-19

4.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Authors:  Zobair M Younossi; Maria Stepanova; Mariam Afendy; Yun Fang; Youssef Younossi; Hesham Mir; Manirath Srishord
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-25       Impact factor: 11.382

5.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel E Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  N Engl J Med       Date:  2010-04-28       Impact factor: 91.245

6.  Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.

Authors:  Soumeya Bekri; Philippe Gual; Rodolphe Anty; Nathalie Luciani; Monsef Dahman; Bala Ramesh; Antonio Iannelli; Aline Staccini-Myx; Dominique Casanova; Imed Ben Amor; Marie-Christine Saint-Paul; Pierre-Michel Huet; Jean-Louis Sadoul; Jean Gugenheim; Surjit Kaila S Srai; Albert Tran; Yannick Le Marchand-Brustel
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

7.  Long-term follow-up of patients with NAFLD and elevated liver enzymes.

Authors:  Mattias Ekstedt; Lennart E Franzén; Ulrik L Mathiesen; Lars Thorelius; Marika Holmqvist; Göran Bodemar; Stergios Kechagias
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

8.  Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.

Authors:  Maria Stepanova; Nila Rafiq; Zobair M Younossi
Journal:  Gut       Date:  2010-07-26       Impact factor: 23.059

Review 9.  Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.

Authors:  Curtis K Argo; Patrick G Northup; Abdullah M S Al-Osaimi; Stephen H Caldwell
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

10.  Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.

Authors:  Elmar Aigner; Igor Theurl; Milan Theurl; Dieter Lederer; Heike Haufe; Otto Dietze; Michael Strasser; Christian Datz; Guenter Weiss
Journal:  Am J Clin Nutr       Date:  2008-05       Impact factor: 7.045
  10 in total
  1 in total

1.  Why vitamin D status should be checked in patients with nonalcoholic fatty liver disease.

Authors:  Luca Mascitelli; Mark R Goldstein; William B Grant
Journal:  Mayo Clin Proc       Date:  2012-08       Impact factor: 7.616
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.